製品: SLC16A4 Antibody
カタログ: DF7145
タンパク質の説明: Rabbit polyclonal antibody to SLC16A4
アプリケーション: WB IHC IF/ICC
Cited expt.: WB
反応性: Human, Mouse, Rat
予測: Pig, Bovine, Horse, Sheep, Rabbit, Dog
分子量: 54kDa; 54kD(Calculated).
ユニプロット: O15374
RRID: AB_2839099

類似製品を見る>>

   サイズ 価格 在庫状況
 100ul $280 在庫あり
 200ul $350 在庫あり

リードタイム: 当日配達

For pricing and ordering contact:
お問い合わせ先

製品説明

ソース:
Rabbit
アプリケーション:
WB 1:1000-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user. For optimal experimental results, antibody reuse is not recommended.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

反応性:
Human,Mouse,Rat
予測:
Pig(92%), Bovine(100%), Horse(92%), Sheep(100%), Rabbit(92%), Dog(92%)
クローナリティ:
Polyclonal
特異性:
SLC16A4 Antibody detects endogenous levels of total SLC16A4.
RRID:
AB_2839099
引用形式: Affinity Biosciences Cat# DF7145, RRID:AB_2839099.
コンジュゲート:
Unconjugated.
精製:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
別名:

折りたたみ/展開

AW146050; MCT4; MCT5; MGC37305; Monocarboxylate transporter 4; Monocarboxylate transporter 5; OTTHUMP00000013008; OTTMUSP00000028710; Solute carrier family 16 (monocarboxylic acid transporters), member 4; Solute carrier family 16 member 4; Solute carrier family 16, member 4 (monocarboxylic acid transporter 5); SLC16A4; MOT5_HUMAN;

免疫原

免疫原:

A synthesized peptide derived from human SLC16A4, corresponding to a region within the internal amino acids.

Uniprot:
遺伝子(ID):
タンパク質の説明:
Proton-linked monocarboxylate transporter. Catalyzes the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, branched-chain oxo acids derived from leucine, valine and isoleucine, and the ketone bodies acetoacetate, beta-hydroxybutyrate and acetate.
タンパク質配列:
MLKREGKVQPYTKTLDGGWGWMIVIHFFLVNVFVMGMTKTFAIFFVVFQEEFEGTSEQIGWIGSIMSSLRFCAGPLVAIICDILGEKTTSILGAFVVTGGYLISSWATSIPFLCVTMGLLPGLGSAFLYQVAAVVTTKYFKKRLALSTAIARSGMGLTFLLAPFTKFLIDLYDWTGALILFGAIALNLVPSSMLLRPIHIKSENNSGIKDKGSSLSAHGPEAHATETHCHETEESTIKDSTTQKAGLPSKNLTVSQNQSEEFYNGPNRNRLLLKSDEESDKVISWSCKQLFDISLFRNPFFYIFTWSFLLSQLAYFIPTFHLVARAKTLGIDIMDASYLVSVAGILETVSQIISGWVADQNWIKKYHYHKSYLILCGITNLLAPLATTFPLLMTYTICFAIFAGGYLALILPVLVDLCRNSTVNRFLGLASFFAGMAVLSGPPIAGWLYDYTQTYNGSFYFSGICYLLSSVSFFFVPLAERWKNSLT

種類予測

種類予測:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Bovine
100
Sheep
100
Pig
92
Horse
92
Dog
92
Rabbit
92
Zebrafish
64
Xenopus
0
Chicken
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

研究背景

機能:

Proton-linked monocarboxylate transporter. Catalyzes the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, branched-chain oxo acids derived from leucine, valine and isoleucine, and the ketone bodies acetoacetate, beta-hydroxybutyrate and acetate (By similarity).

細胞の位置付け:

Cell membrane>Multi-pass membrane protein.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
タンパク質ファミリー:

Belongs to the major facilitator superfamily. Monocarboxylate porter (TC 2.A.1.13) family.

参考文献

1). Self-activated prodrug nanocomposites reprogramming lactic acid metabolism to initiate acidosis-endoplasmic reticulum stress cascade and potentiate immunogenic cell death for enhanced liver cancer therapy. Journal of nanobiotechnology, 2025 (PubMed: 41327195) [IF=10.2]

Application: WB    Species: Mouse    Sample: H22 cell

Figure 3. GD-A effectively inhibits lactic acid efflux in vitro and reverses the pH gradient. A) Cellular mechanism by which GD-A NPs inhibit lactate efflux and enhance tumor acidosis. B-C) Green fluorescence images of intracellular H₂S generation in H22 cells following co-incubation with PBS, As3+, As5+,Zn2+,GYY4137, DCF, GD NPs, and GD-A NPs, along with corresponding fluorescence intensity analysis (n=3), scale bar:50 μm. D) CLSM images of mitochondrial membrane potential fluorescence probes in H22 cells co-incubated with PBS, As³⁺, As⁵⁺, GD NPs, and GD-A NPs for 6 h, scale bar: 20 μm. E) Representative western blots of different protein levels in H22 cells after treatment with different groups. FG) Analysis of intracellular and extracellular lactate levels in H22 cells after 24 h of treatment under different conditions (n=3). H-I) Changes in intracellular pH in H22 cells after co-culture under different treatment conditions, along with the corresponding fluorescence quantification. scale bar: 50 μm.Results are expressed as mean ± SD; differences from the control group are denoted by * p

2). The effect of glycolytic enzyme expression and thyroiditis on the aggressiveness of papillary thyroid carcinoma: a retrospective cohort study. Annals of surgical treatment and research, 2025 (PubMed: 41000235) [IF=1.2]

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.